Eton Pharmaceuticals, Inc.
ETONNasdaqCIK 1710340HealthcareFiscal year ends Dec 31
Reports and events: 203 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1411:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-032600 |
| 2026-09-2811:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-031281 |
| 2026-08-1320:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027684 |
| 2026-08-1320:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027672 |
| 2026-08-0511:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-025781 |
| 2026-08-0411:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-025506 |
| 2026-07-2911:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024746 |
| 2026-06-0920:31 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-020005 |
| 2026-05-1920:45 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-017799 |
| 2026-05-1420:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017064 |
| 2026-05-1420:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-017063 |
| 2026-05-0111:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014315 |
| 2026-04-2711:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-013369 |
| 2026-04-2420:05 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001437749-26-013313 |
| 2026-04-1611:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012488 |
| 2026-04-1520:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-012381 |
| 2026-03-1920:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-009059 |
| 2026-03-1920:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-009060 |
| 2026-03-0212:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-26-006209 |
| 2026-02-2519:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-005537 |
| 2026-02-0212:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-002605 |
| 2025-12-0412:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-036853 |
| 2025-11-1821:16 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-25-035597 |
| 2025-11-0621:28 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-033619 |
| 2025-11-0621:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-033616 |
| 2025-08-0720:23 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025444 |
| 2025-08-0720:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025438 |
| 2025-07-0811:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-022298 |
| 2025-06-2711:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-021383 |
| 2025-06-2020:17 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-020916 |
| 2025-06-1020:17 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-019983 |
| 2025-05-2821:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-018698 |
| 2025-05-1320:21 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016475 |
| 2025-05-1320:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016468 |
| 2025-05-0220:37 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 8.01 Other events | 0001437749-25-014334 |
| 2025-04-2811:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013227 |
| 2025-04-2520:16 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001437749-25-013137 |
| 2025-04-0111:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-010358 |
| 2025-03-1816:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-008163 |
| 2025-03-1811:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-008137 |
| 2025-03-1811:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-008136 |
| 2025-03-1411:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-007615 |
| 2025-03-0721:16 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 8.01 Other events | 0001437749-25-006678 |
| 2025-03-0312:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-005799 |
| 2025-02-0712:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-003070 |
| 2025-02-0611:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-002935 |
| 2025-01-0312:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-25-000109 |
| 2024-12-2012:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-24-038020 |
| 2024-12-1712:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-037689 |
| 2024-12-1221:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-037367 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.